Indication · GI, Urology & Nephrology
Enlarged prostate (BPH)
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
158
Cleared or approved since 2000
PMA and De Novo
25
Higher-risk or first-of-kind devices
Breakthrough devices
1
Authorized through June 30, 2026
Recruiting device trials
102
823 device trials in all
Breakthrough-designated devices
- Vanquish Water Vapor Ablation DeviceFrancis Medical, Inc. · 2025
Devices
21 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Urologix Targis System
Urologix, LLC · PMA · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy · newest 2015 · 16 decisions
- Prolieve Thermodilatation System
Medifocus, Inc. · PMA · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy · newest 2007 · 8 decisions
- TMX-2000 Bph
Boston Scientific Corp · PMA · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy · newest 2004 · 6 decisions
18 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
The Methodist Hospital Research InstituteAcademic, hospital or other
NCT07948330 · 23 participants (planned) · Start Sep 16, 2026 · Primary completion Oct 1, 2027
Device: Magstim - rTMS system · For: Urinary Incontinence; Prostate Treatment; Incontinence After Prostate Treatment
Sites: Houston, Texas
General University Hospital, PragueAcademic, hospital or other
NCT07939061 · 47 participants (planned) · Start Sep 3, 2026 · Primary completion Jun 1, 2028
Device: Active peroneal transcutaneous neuromodulation (URIS I, Stimvia); Sham peroneal transcutaneous neuromodulation (URIS I, Stimvia) · For: Overactive Bladder; Daytime Urinary Incontinence
Sites: Prague, Czechia
- A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)Active, not recruiting
UroMems SASNot on our public-company list
NCT06968741 · 140 participants (planned) · Start May 19, 2025 · Primary completion Dec 2026
Device: Artificial Urinary Sphincter (AUS) · For: Stress Urinary Incontinence (SUI)
Sites: Los Angeles, California; San Francisco, California; Stanford, California · 19 sites in all
820 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS)77
- Electrode, Electrosurgical, Active, Urological (FAS)21
- System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)14
- System, Irrigation, Urological (LJH)13
- Resectoscope (FJL)10
- Implantable Transprostatic Tissue Retractor System (PEW)5
- Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY)4
- Stent, Urethral, Bulbous, Permanent Or Semi-Permanent (MES)3
- Uroflowmeter (EXY)2
- Stent, Urethral, Prostatic, Permanent Or Semi-Permanent (MER)2
- Fluid Jet Removal System (PZP)2
- Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia (QKA)2
- Resectoscope, Working Element (FDC)1
- Stent, Urethral, Prostatic, Semi-Permanent (NZC)1
- Drug Coated Prostatic Dilation Catheter For Benign Prostatic Hyperplasia (QXB)1
Research
- Device studies on benign prostatic hyperplasia across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.